Ramesh Kumar's Net Worth
$765 Thousand
Who is Ramesh Kumar?
Ramesh Kumar does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Ocugen, Inc., and Onconova Therapeutics, Inc..
SEC CIK
Ramesh Kumar's CIK is 0001580074
Past Insider Trading and Trends
2013 was Ramesh Kumar's most active year for acquiring shares with 14 total transactions. Ramesh Kumar's most active month to acquire stocks was the month of June. 2013 was Ramesh Kumar's most active year for disposing of shares, totalling 10 transactions. Ramesh Kumar's most active month to dispose stocks was the month of June. 2016 saw Ramesh Kumar paying a total of $208,136.50 for 291,949 shares, this is the most they've acquired in one year. In 2014 Ramesh Kumar cashed out on 173,543 shares for a total of $1,205,200.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Ocugen, Inc. (OCGN) Snapshot price: $0.5153
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
$1.17 | -$5,940.00 |
0
|
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$1.54 | -$15,450.00 |
0
|
Scheduled
|
Jul 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
$1.67 | -$17,400.00 |
0
|
Scheduled
|
Apr 18
| ||
Form 4
|
—
|
0
|
$2.29 | -$26,700.00 |
0
|
Scheduled
|
Jan 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
$4.32 | -$57,150.00 |
0
|
Scheduled
|
Oct 18
| ||
Form 4
|
—
|
0
|
$3.46 | -$44,175.00 |
0
|
Scheduled
|
Jul 19
| ||
Form 4
|
—
|
0
|
$2.92 | -$36,150.00 |
0
|
Scheduled
|
Apr 19
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Onconova Therapeutics, Inc. (ONTX) Snapshot price: $0.6726
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +30.36% | 23.81K |
$2.10 | $50,001.00 | 102.23K |
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
| +183.59% | 50.77K |
$4.10 | $208,136.50 | 78.42K |
Jul 26 - Jul 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
$10.54 | -$304,357.86 | 276.5K |
Scheduled
|
Feb 7 - Feb 10
| ||
Form 4
|
—
|
0
|
$10.38 | -$560,502.48 | 276.5K |
Scheduled
|
Jan 30 - Feb 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
| +0.40% | 1.1K |
$12.02 | $13,222.00 | 276.5K |
Nov 15
| |||
Form 4
| +13.36% | 32.45K |
$15.00 |
—
| 275.4K |
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||